Thomas Hallam, outgoing Palisade Bio CEO
Another biotech CEO departs, leaving behind few employees for PhIII
A month after laying off 20% of its employees, Palisade Bio’s CEO is also out the door. Thomas Hallam hit the exit on Monday and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.